Stephen Neeleman - 25 Jul 2024 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role
FOUNDER AND VICE CHAIRMAN, Director
Signature
/s/ Stephen Neeleman
Issuer symbol
HQY
Transactions as of
25 Jul 2024
Net transactions value
-$2,305,130
Form type
4
Filing time
29 Jul 2024, 16:34:50 UTC
Previous filing
08 Jul 2024
Next filing
07 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Options Exercise $338,632 +24,188 +27% $14.00 113,957 25 Jul 2024 Direct F1
transaction HQY Common Stock Sale $1,928,543 -24,188 -21% $79.73 89,769 25 Jul 2024 Direct F1, F2
transaction HQY Common Stock Options Exercise $151,368 +10,812 +12% $14.00 100,581 25 Jul 2024 Direct F1
transaction HQY Common Stock Sale $866,587 -10,812 -11% $80.15 89,769 25 Jul 2024 Direct F1, F3
holding HQY Common Stock 559,235 25 Jul 2024 See footnote F4
holding HQY Common Stock 203,000 25 Jul 2024 See footnote F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HQY Stock Option (right to buy) Options Exercise $0 -24,188 -69% $0.000000 10,812 25 Jul 2024 Common Stock 35,000 $14.00 Direct F1, F6
transaction HQY Stock Option (right to buy) Options Exercise $0 -10,812 -100% $0.000000* 0 25 Jul 2024 Common Stock 10,812 $14.00 Direct F1, F6
holding HQY Stock Option (right to buy) 19,897 25 Jul 2024 Common Stock 19,897 $41.28 Direct F6
holding HQY Stock Options (right to buy) 14,228 25 Jul 2024 Common Stock 14,228 $61.72 Direct F6
holding HQY Stock Options (right to buy) 15,337 25 Jul 2024 Common Stock 15,337 $73.61 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 08, 2023.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.9600 to $79.9550, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) of this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.9600 to $80.4000, inclusive.
F4 Shares held of record by the Stephen and Christine Neeleman Trust.
F5 Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.
F6 The option is immediately exercisable.